Equillium (EQ) to Release Quarterly Earnings on Monday

Equillium (NASDAQ:EQ) is expected to be announcing its earnings results before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.22) per share for the quarter.

Equillium Price Performance

Shares of NASDAQ:EQ opened at $0.75 on Monday. The company has a market cap of $26.75 million, a price-to-earnings ratio of -5.39 and a beta of 1.87. The firm has a 50 day simple moving average of $0.76 and a 200 day simple moving average of $0.81. Equillium has a one year low of $0.49 and a one year high of $2.99.

About Equillium

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis.